Koichi Matsuzaki

Hirakata, 5731010, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.

Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.

Journal: International journal of molecular sciences

Published: April 18, 2022

Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.

Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.

Journal: Frontiers in bioscience (Landmark edition)

Published: September 18, 2021

Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.

Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: December 03, 2019

Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.

Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.

Journal: Cancers

Published: April 30, 2018

Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.

Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.

Journal: Pancreas

Published: January 19, 2017

Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.

Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.

Journal: Journal of clinical medicine

Published: November 18, 2015

S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

Journal: Molecular and clinical oncology

Published: November 09, 2015

Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation.

Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation.

Journal: Nature communications

Published: March 29, 2015

Severe acute hepatitis in a printing company worker: a case study.

Severe acute hepatitis in a printing company worker: a case study.

Journal: Journal of occupational health

Published: November 21, 2014

TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review).

TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review).

Journal: International journal of oncology

Published: April 09, 2014

Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report.

Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report.

Journal: Oncology letters

Published: March 13, 2014

Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.

Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: December 26, 2013

Showing 1-12 of 30

Last Updated: 09/26/2026